Welcome to LookChem.com Sign In|Join Free
  • or
tert-butyl 3-(Methylsulfonyl)pyrrolidine-1-carboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1430727-41-5

Post Buying Request

1430727-41-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1430727-41-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1430727-41-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,3,0,7,2 and 7 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1430727-41:
(9*1)+(8*4)+(7*3)+(6*0)+(5*7)+(4*2)+(3*7)+(2*4)+(1*1)=135
135 % 10 = 5
So 1430727-41-5 is a valid CAS Registry Number.

1430727-41-5Relevant academic research and scientific papers

Protected Chloroethyl and Chloropropyl Amines as Conformationally Unrestricted Annulating Reagents

Shi, Qing,Meehan, Mariah C.,Galella, Michael,Park, Hyunsoo,Khandelwal, Purnima,Hynes, John,Dhar, T. G. Murali,Marcoux, David

supporting information, p. 337 - 340 (2018/01/28)

The purpose of this letter is to document the use of protected chloroethyl and chloropropyl amines as conformationally unrestricted ambiphilic reagents that undergo annulation reactions with Michael acceptors. This reaction is wide in scope and utilizes r

PROTEIN KINASE INHIBITORS

-

Page/Page column 31, (2014/10/18)

A compound of formula (I), wherein R1 to R5, A, B, Z, Z1 and Z2 are as defined in the claims, and pharmaceutically acceptable salts thereof are disclosed. The compounds of formula (I) possess utility as FGFR inhibitors and are useful in the treatment of a condition, where FGFR kinase inhibition is desired, such as cancer.

PROTEIN KINASE INHIBITORS

-

Page/Page column 46; 47, (2013/04/25)

A compound of formula (I), wherein R3, R4, G, B, M, and Z are as defined in the claims, and pharmaceutically acceptable salts thereof are disclosed. The compounds of formula (I) possess utility as FGFR inhibitors and are useful in the treatment of a condition, where FGFR kinase inhibition is desired, such as cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1430727-41-5